Clinical Trials Search Results | Moffitt

Disease Site

Keyword

Study Type

Medication

Therapy

Principal Investigator

NCT#

Study Phase

1

2

3

4

361 Clinical Trials Found

Order By

Clinical Trial 22617

Disease Site: Breast

PI: Soyano Muller, Aixa

Clinical Trial 20110

GBM Agile: Global Adaptive Trial Master Protocol

Disease Site: Brain and Nervous System

PI: Grogan, Patrick

Clinical Trial 21131

A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features

Disease Site: Larynx, Lip, Oral Cavity and Pharynx, Head & Neck

PI: Kirtane, Kedar

Clinical Trial 21917

A Phase II Study Of Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Overexpressing Gastroesophageal Cancers

Disease Site: Other

PI: Kim, Dae Won

Clinical Trial 21971

Phase I Clinical Trial of CD40L-augmented Tumor Infiltrating Lymphocytes (CD40L TIL) for Patients with Oncogene-Driven Advanced Non-Small Cell Lung Cancer (NSCLC)

Disease Site: Lung

PI: Creelan, Benjamin

Clinical Trial 22286

Disease Site: Leukemia, other

PI: Shah, Bijal

Clinical Trial 23448

Disease Site: Anus, Any Site, Colon, Corpus Uteri, Lung, Other Digestive Organ, Pancreas, Rectum

PI: Biachi de Castria, Tiago

Clinical Trial 23486

Disease Site: Brain and Nervous System

PI: Oliver, Daniel

Clinical Trial 23562

Disease Site: Prostate

PI: Grass, George (Daniel)

Clinical Trial 23548

A Phase 1, Open-Label, Dose Escalation and Expansion Study of STX-0712 in Patients with Advanced Hematologic Malignancies

Disease Site: Soft Tissue

PI: Padron, Eric

Clinical Trial 23564

Disease Site: Soft Tissue

PI: Alsina, Melissa

Clinical Trial 23599

Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-11818 in Subjects with Advanced KRAS Mutant Cancers

Disease Site: Anus, Any Site, Colon, Lung, Pancreas, Rectum

PI: Haura, Eric

Previous
1
...
2
3
4
5
6
7
8
...
31
Next